Difficult targets in small molecule drug discovery

Katherina Orellana, Head of Business Development Europe at Axxam, is pleased to introduce a seminar featuring Iolanda Micco, where she explores the potential of small molecules to tackle “undruggable targets”.

Abstract for the talk: The disease relevance and druggability of novel targets rarely align. However, emerging drug mechanisms and modalities are reshaping our perspective on “undruggable targets.” We will explore how to utilize effective lead-finding strategies to tackle challenging targets with small molecules.